SEC Form 4 · accession 0001654954-17-011696

CorMedix Inc. · CRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Nov 6, 2017

Accepted (ET)

Dec 15, 2017 · 4:01 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001410098

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	284,166	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F1	—	Nov 6, 2017	A	5,000	A	—	—	Common Stock	5,000	5,000	D
Stock Option (Right to Buy Common Stock)^F2	$2.24	holding	—	—	—	—	Feb 21, 2027	Common Stock	40,000	40,000	D
Restricted Stock Units^F3	—	holding	—	—	—	—	—	Common Stock	10,000	10,000	D
Stock Option (Right to Buy Common Stock)^F4	$4.28	holding	—	—	—	—	Apr 28, 2026	Common Stock	50,000	50,000	D

F1The restricted stock units were granted on 11/6/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of November 6, 2017, subject to continued service on the board.
F2These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
F3These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
F4These options were granted on 4/28/2016. These options shall vest as follows: 1/3 on 4/28/2016, 1/3 on 4/28/2017, and 1/3 on 4/28/2018.